Kentucky Launches Probe into Drug Overcharges by Pharmacy Benefit Managers
Ohio Accuses UnitedHealth’s OptumRx of Drug Overcharges
Early Activity Holds Signs of Hope for 2019 State Legislative Cycle
Eli Lilly Backs U.S. Proposal on Drug Rebates to Lower Costs
U.S. Government Proposes Rule Overhauling Drug Industry Rebate System
ACR’s Affiliate Society Council Reports Solid Gains in Advocacy Efforts
ACR/ARHP Members Call on Congress to Restore Patients’ Voices
FDA’s Gottlieb Eyes PBM Consolidation Impact on Generic Entry: CNBC
